Medicaid Expansion Did not Improve Time to Treatment for Young Patients With Metastatic Renal Cell Carcinoma

Anuj S. Desai*, Minh Pham, Adam B. Weiner, Mohammad R. Siddiqui, Conor Driscoll, Ketan Jain-Poster, Oliver S. Ko, Amanda Vo, Shilajit D. Kundu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

We assessed whether Medicaid expansion has led to more timely treatment of metastatic renal cell carcinoma (mRCC). We compared the time to treatment before and after expansion between the states that had and had not expanded Medicaid for patients with mRCC within the National Cancer Database. Medicaid expansion was not associated with more timely treatment for patients with mRCC.

Original languageEnglish (US)
Pages (from-to)e386-e390
JournalClinical Genitourinary Cancer
Volume18
Issue number4
DOIs
StatePublished - Aug 2020

Keywords

  • Epidemiology
  • Health Insurance
  • Patient Protection and Affordable Care Act
  • United States
  • mRCC

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Medicaid Expansion Did not Improve Time to Treatment for Young Patients With Metastatic Renal Cell Carcinoma'. Together they form a unique fingerprint.

Cite this